 |
EnGeneIC delivery vehicles loaded with doxorubicin and targeted to tumor with sequences from Vectibix and mouse monoclonal antibody |
|---|---|
| Trade Name | |
| Orphan Indication | Glioblastoma |
| USA Market Approval | USA |
| USA Designation Date | 2017-02-14 00:00:00 |
| Sponsor | EnGeneIC Ltd;25 Sirius Road, Building 2;Lane Cove West |
